Mathieu Simon, MD, has served as Executive Vice-President, Chief Executive Officer of Cellectis Therapeutics since 2012 and as Chief Operating Officer of Cellctis since 2013.
Dr. Mathieu Simon is also Member of Cellectis, Board of Directors since 2013 and sits at the board of Vaximm a Swiss-based biotechnology company headquarted in Basel, Switzerland.
Prior to joining Cellectis, Dr. Simon was Senior Vice President Head of Global Pharmaceutical Operations at Pierre Fabre SA.
From 1994 to 2010, Dr. Simon has served at Wyeth Pharmaceuticals in both senior corporate and regional roles (Head of International Marketing and Medical Affairs and Managing Director of several Wyeth Affiliates).
Since 2014, Dr. Simon is an advisor at the European Commission D.G. Research and Innovation with a special expertise in market access and reimbursement initiatives and partner at Scientifica (Venture Capital Fund).